← Evidence map

ArticleAAPS PharmSciTech2026

Reverse Engineering of Branded Mesalamine Prolonged Release Granules for Synthesis of QTPP and FMEA: A Systematic Approach for Oral Complex Generic Product Development.

Sadhana Dhyagala et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

Reverse Engineering of Branded Mesalamine Prolonged Release Granules for Synthesis of QTPP and FMEA: A Systematic Approach for Oral Complex Generic Product Development. | Socratic